 |
市場調査レポート
商品コード
950716
COVID-19対応フェイスマスクと製造工場の世界市場：2020年～2024年COVID-19 Face Masks and Face Masks Manufacturing Plants Market 2020-2024 |
||||||
Homeland Security Research Corporation (HSRC)| COVID-19対応フェイスマスクと製造工場の世界市場：2020年～2024年 |
|
出版日: 2020年07月24日
発行: Homeland Security Research Corporation (HSRC)
ページ情報: 英文 150 Pages; 120 Tables & Figures
納期: 即日から翌営業日
|
新型コロナウイルス感染症（COVID-19）のパンデミック抑制に不可欠な対策の1つは、個人用保護具（PPE）の使用であり、各国の医療従事者のコミュニティと政府が市民にPPE、特にフェイスマスクを使用するよう啓発する取り組みが感染の拡大を抑えて経済を回復させるための決め手となります。
現在PPEの大部分を製造しているのは中国であり、パンデミックが続くなか同国の企業は増産に追われています。しかし需要の爆発的な増加にともない、詐欺や偽造品も急増しており、2020年4月には中国政府が偽造PPEを取り締まるための措置を講じています。
当レポートは、世界のCOVID-19対応フェイスマスクと製造工場の市場を調査したもので、成長促進要因と阻害要因、ビジネスチャンス、SWOT分析、競合分析、事業環境などの情報を提供しています。
It is now widely agreed upon that an essential remedy to the suppression of the pandemic is the use of Personal Protective Equipment (PPE). The ability to curb the spread of the pandemic and minimize new surges so that the economy will recover, largely depends on how well the healthcare community and governments will educate their citizens to use Personal Protection Gear, especially face masks.
Currently, China manufactures the majority of the globe's PPE. During Q1 2020, as the coronavirus tore through China and it went into lockdown, Chinese PPE factories ramped up their production. As China started to re-open its economy as the pandemic continued spreading throughout the rest of the world, demand for Personal Protection Gear soared to the point that factory owners in the industry began boasting that they owned money printing machines. As orders of consumer goods shrunk, anxious manufacturers, who had the clean rooms and know-how needed to make PPE, switched their production lines over to make face masks, gloves and PPE gowns.
With demand exploding, full payment up front became the norm. Fraud and counterfeit products proliferated. In April 2020, the PRC government rolled out actions intended to clamp down on counterfeit PPE, and it became even trickier to ship products out of China. For many Chinese tech companies, swooping in as the savior is shrewd publicity. "They have the funds and the political clout, and it's good for their business mission," says J. Norwell Coquillard, executive director of the Washington State China Relations Council, a Seattle-based lobbying group helping local health-care buyers vet Chinese suppliers of PPE.
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.
To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:
比較リスト
